NMD4C Hire Research Software Developer
New Research Software Developer
The NMD4C are pleased to announce the hiring of research software developer Kevin LaFleur to the network’s biobanking team! Kevin holds a bachelor’s degree in music and cognitive science from McGill University and brings experience from technical and research assistant roles at labs and research groups in Montreal and Boston, most recently at Tore Nielsen’s Dream and Nightmare Lab at UdeM.
Role of the Developer
As a research software developer for the NMD4C and the Montreal Neurological Institute, Kevin works with Dr. Jason Karamchandani to develop the technical infrastructure for a centralized Canadian neuromuscular biobanking catalogue. Kevin works to link biospecimen, imaging and genetic information from neuromuscular biobanks across Canada to a central repository within the Neuro’s C-BIG project.
Read next...
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.
Advancing AFC in Neuromuscular Medicine: Program Launch & September Workshop
The Royal College has approved National Training Standards for the AFC in Neuromuscular Medicine, creating a formal pathway to recognize enhanced competence with the DRCPSC credential. This designation establishes a national training standard, supports portable certification, and strengthens clinical capacity across Canada. PGME offices can now apply to offer accredited AFC programs, with a goal of five programs submitting applications by the end of 2026.